Rituximab likely raises risk of hospital death in COVID-19 patients
December 2, 2021
In a retrospective study of hospitalized COVID-19 patients, “only 1 of 303 drugs examined, rituximab, was associated with an increased risk of in-hospital death ... both when used for rheumatologic as well as for cancer therapy.”
Undertriaging linked to worse outcomes in postop patients
November 19, 2021
Every story needs a teaser. Must differ from the headline. Meeting stories need a dateline. 150 characters or fewer.
COVID toes and seasonal chilblains share similar immune responses
October 18, 2021
"This thoughtfully designed study provides additional support to the notion that there is likely a direct relationship with COVID-19 infection and CLLs."
When can uncomplicated acute appendicitis in adults be treated nonoperatively?
October 18, 2021
Appendiceal diameter greater than or equal to 15 mm on CT and a body temperature of more than 38 °C on admission were associated with primary nonresponsiveness to antibiotic therapy.
Fluid type, rate do not curb 90-day mortality rate in ICU patients requiring fluid challenges
August 17, 2021
A balanced solution was no better than normal saline and a slower IV bolus rate was no better than a faster rate in a multicenter randomized trial.
Fecal microbiota transplantation impacts microRNAs implicated in recurrent C. difficile
May 4, 2021
“The findings from this study are extremely exciting and promising for the creation of novel therapeutics for patients with C. difficile.”
Report Shows Implanted Cardioveter-defibrillators Carries High Risk
May 11, 2016
NEW YORK (Reuters Health) - Implanted cardioverter-defibrillators (ICDs) carry a high risk of long-term complications, especially for younger patients, women, and blacks, researchers report. Early implantation-related risks such as device malfunction are well known, but longer-term risks -- espec
Metal-on-Metal Hip Replacement Devices Implanted after 2006 have a High Revision Rate
May 6, 2016
NEW YORK (Reuters Health) - Certain metal-on-metal (MoM) hip replacement devices implanted after 2006 have an "unacceptably high" revision rate, due mainly to manufacturing problems, according to a new study. "Although the use of MoM hip devices has declined dramatically in the past five years, h
Study Shows Certain Elderly Patients on Warfarin Therapy are at Greater Risk for Traumatic Intracranial Bleeding
March 17, 2016
NEW YORK (Reuters Health) - Certain older patients on warfarin therapy are at greater risk than others for traumatic intracranial bleeding, Veterans Affairs researchers have reported. In their study of elderly adults receiving warfarin for atrial fibrillation (AF), five factors - dementia, anemia